These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8590314)

  • 1. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons.
    Brod SA; Scott M; Burns DK; Phillips JT
    J Interferon Cytokine Res; 1995 Feb; 15(2):115-22. PubMed ID: 8590314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.
    Brod SA; Khan M
    J Autoimmun; 1996 Feb; 9(1):11-20. PubMed ID: 8845048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
    Gold DP; Schroder K; Powell HC; Kelly CJ
    Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis.
    Brod SA; Khan M; Kerman RH; Pappolla M
    J Neuroimmunol; 1995 Apr; 58(1):61-9. PubMed ID: 7537281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased production of TNF-alpha by lymph node cells indicates experimental autoimmune encephalomyelitis remission in Lewis rats.
    Seger J; Zorzella-Pezavento SF; Pelizon AC; Martins DR; Domingues A; Sartori A
    Mem Inst Oswaldo Cruz; 2010 May; 105(3):263-8. PubMed ID: 20512238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ; Roberts CM; Waxman FJ
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
    Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
    J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell immunity and interferon-gamma secretion during experimental allergic encephalomyelitis in Lewis rats.
    Mustafa MI; Diener P; Höjeberg B; Van der Meide P; Olsson T
    J Neuroimmunol; 1991 Feb; 31(2):165-77. PubMed ID: 1704016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
    Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
    Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
    Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
    J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
    Killen JA; Swanborg RH
    J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.
    Whitacre CC; Gienapp IE; Orosz CG; Bitar DM
    J Immunol; 1991 Oct; 147(7):2155-63. PubMed ID: 1717550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of self tolerance in experimental allergic encephalomyelitis. I. Differences between lymph node and spleen suppressor cells.
    Welch AM; Swierkosz JE; Swanborg RH
    J Immunol; 1978 Nov; 121(5):1701-5. PubMed ID: 309479
    [No Abstract]   [Full Text] [Related]  

  • 18. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
    Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats treated with fucoidan.
    Kim H; Moon C; Park EJ; Jee Y; Ahn M; Wie MB; Shin T
    Phytother Res; 2010 Mar; 24(3):399-403. PubMed ID: 19655293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons.
    Brod SA; Burns DK
    Neurology; 1994 Jun; 44(6):1144-8. PubMed ID: 8208413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.